학술논문
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study
Document Type
Article
Author
Source
In: Annals of Oncology . (Annals of Oncology, May 2012, 23(5):1121-1129)
Subject
Language
English
ISSN
09237534
15698041
15698041